Loading
Latest filing published 02 Aug 2007 for BIOENVISION INC, €34.2M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Genzyme Corp in Bioenvision Inc. Altogether 3 filings, all relating to 10 July 2007.
Every open-market trade on record is a purchase: 3 purchases worth €104.7M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €35.1M.
The latest filing, published on 2 August 2007, reports an open-market purchase of €34.2M in Bioenvision Inc. The median gap between a trade and its publication by SEC (Form 4) is 6 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations